Interrelation between the Metabolism of L-Isoleucine and L-Allo-Isoleucine in Patients with Maple Syrup Urine Disease

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Pediatric Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1203/00006450-198901000-00003PMID 2919111
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Utilization of the L- and DL-isomers of alpha-keto-beta-methylvaleric acid by rats and comparative efficacy of the keto analogs of branched-chain amino acids provided as ornithine, lysine and histidine salts.

  1987cited by this paper
• Comparison of the Catabolism of Branched-Chain L-Amino Acids in Cultured Human Skin Fibroblasts

  1987cited by this paper
• Thiamine Response in Maple Syrup Urine Disease

  1985cited by this paper
• Organic acids and branched-chain amino acids in body fluids before and after multiple exchange transfusions in maple syrup urine disease

  1983cited by this paper
• Maple-syrup-urine disease.

  1983cited by this paper
• Maple syrup urine disease: alpha-ketoisocaproate decarboxylation activity in different types of cultured amniotic fluid cells.

  1981cited by this paper
• Alloisoleucine Formation in Maple Syrup Urine Disease: Isotopic Evidence for the Mechanism

  1980cited by this paper
• Correlations between branched-chain amino acids and branched-chain alpha-keto acids in blood in maple syrup urine disease.

  1978cited by this paper
• Racemization and amination of the keto-analog of isoleucine in the intact dog.

  1977cited by this paper
• Demonstration of a new mammalian isoleucine catabolic pathway yielding an Rseries of metabolites.

  1976cited by this paper
• Enzyme activity in classical and variant forms of maple syrup urine disease.

  1972cited by this paper
• The configuration of the alloisoleucine present in maple syrup urine disease plasma.

  1970cited by this paper
• MAPLE SYRUP URINE DISEASE, WITH PARTICULAR REFERENCE TO DIETOTHERAPY.

  1964cited by this paper
• A new finding in maple-syrup-urine disease.

  1962cited by this paper
• Studies on d- and tau-alpha-keto-beta-methylvaleric acids.

  1951cited by this paper
• Growth response of the rat to the keto analogues of leucine and isoleucine.

  1951cited by this paper

• Covalent Docking to the Active Sites of Thiamine Diphosphate-Dependent Enzymes

  2025cites this paper
• The chemical mechanisms of the enzymes in the branched-chain amino acids biosynthetic pathway and their applications.

  2021cites this paper
• Development of Second-Tier Liquid Chromatography-Tandem Mass Spectrometry Analysis for Expanded Newborn Screening in Japan

  2021cites this paper
• The altered human serum metabolome induced by a marathon

  2018cites this paper
• The tip and hidden part of the iceberg: Proteinogenic and non-proteinogenic aliphatic amino acids.

  2017cites this paper
• d-Amino Acid Levels in Perfused Mouse Brain Tissue and Blood: A Comparative Study.

  2017cites this paper
• Deciphering the Biosynthetic Origin of L-allo-Isoleucine.

  2016cites this paper
• Identification of Two Novel BCKDHB Mutations in Korean Siblings with Maple Syrup Urine Disease Showing Mild Clinical Presentation

  2014cites this paper
• Diagnostik der Ahornsirupkrankheit (MSUD) mit besonderer Betrachtung der Mutationsanalyse der BCKDHA-, BCKDHB- und DBT-Gene

  2010cites this paper
• Molekulargenetische Charakterisierung türkisch-stämmiger Patienten mit Ahornsirupkrankheit (MSUD) und geografische Verteilung der Mutationssequenzen in der Türkei

  2009cites this paper
• Sensory-motor polyneuropathy occurring in variant maple syrup urine disease

  2008cites this paper
• Mutational spectrum of maple syrup urine disease in Spain

  2006cites this paper
• Variant maple syrup urine disease (MSUD)—The entire spectrum

  2006cites this paper
• Behandlungsqualität und intellektuelles, neurologisches und schulisch-berufliches Outcome bei der klassischen Form der Ahornsirupkrankheit (MSUD)

  2003cites this paper
• Identification of twelve novel mutations in patients with classic and variant forms of maple syrup urine disease

  2003cites this paper
• Formation of L-Alloisoleucine In Vivo : An L-[13C]Isoleucine Study in Man

  2000cites this paper
• Liver transplantation in maple syrup urine disease

  1999cites this paper
• Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease.

  1999cites this paper
• Leucine Oxidation in vivo: Inter-and Intraindividual Variation in Healthy Subjects as Assessed by Oral L-[1-13C]Leucine Loads

  1994cites this paper
• Molecular genetic characterization of maple syrup urine disease in European families.

  1993cites this paper
• Diurnal changes in cortisol level, neutrophil number and lyzozyme activity in foals during the first 13 weeks of life and in their lactating mothers.

  1992cites this paper
• Determination of (S)- and (R)-2-oxo-3-methylvaleric acid in plasma of patients with maple syrup urine disease.

  1992cites this paper
• Maple syrup urine disease: Interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination

  1992cites this paper
• Oral L-Alloisoleucine Loading Studies in Healthy Subjects and in Patients with Maple Syrup Urine Disease

  1991cites this paper
• On the mechanism of L-alloisoleucine formation: studies on a healthy subject and in fibroblasts from normals and patients with maple syrup urine disease.

  1990cites this paper
• On the mechanism ofl-alloisoleucine formation: Studies on a healthy subject and in fibroblasts from normals and patients with maple syrup urine disease

  1990cites this paper
• Inborn Metabolic Diseases

  1990influential citation
• Disorders of Branched-Chain Amino Acid Metabolism

  1990cites this paper
• Analysis of maple syrup urine disease in cell culture: use of substrates.

  1989cites this paper